445 related articles for article (PubMed ID: 27197215)
1. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks.
Sebestyén E; Singh B; Miñana B; Pagès A; Mateo F; Pujana MA; Valcárcel J; Eyras E
Genome Res; 2016 Jun; 26(6):732-44. PubMed ID: 27197215
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.
Tsai YS; Dominguez D; Gomez SM; Wang Z
Oncotarget; 2015 Mar; 6(9):6825-39. PubMed ID: 25749525
[TBL] [Abstract][Full Text] [Related]
3. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.
Sveen A; Kilpinen S; Ruusulehto A; Lothe RA; Skotheim RI
Oncogene; 2016 May; 35(19):2413-27. PubMed ID: 26300000
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of alternative transcripts in human breast cancer.
Wen J; Toomer KH; Chen Z; Cai X
Breast Cancer Res Treat; 2015 Jun; 151(2):295-307. PubMed ID: 25913416
[TBL] [Abstract][Full Text] [Related]
5. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
6. The role of alternative splicing in cancer.
Singh B; Eyras E
Transcription; 2017 Mar; 8(2):91-98. PubMed ID: 28005460
[TBL] [Abstract][Full Text] [Related]
7. Genome Sequencing and RNA-Motif Analysis Reveal Novel Damaging Noncoding Mutations in Human Tumors.
Singh B; Trincado JL; Tatlow PJ; Piccolo SR; Eyras E
Mol Cancer Res; 2018 Jul; 16(7):1112-1124. PubMed ID: 29592900
[TBL] [Abstract][Full Text] [Related]
8. Identification of recurrent regulated alternative splicing events across human solid tumors.
Danan-Gotthold M; Golan-Gerstl R; Eisenberg E; Meir K; Karni R; Levanon EY
Nucleic Acids Res; 2015 May; 43(10):5130-44. PubMed ID: 25908786
[TBL] [Abstract][Full Text] [Related]
9. Splicing-factor alterations in cancers.
Anczuków O; Krainer AR
RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated regulation of alternative splicing.
Venables JP; Klinck R; Koh C; Gervais-Bird J; Bramard A; Inkel L; Durand M; Couture S; Froehlich U; Lapointe E; Lucier JF; Thibault P; Rancourt C; Tremblay K; Prinos P; Chabot B; Elela SA
Nat Struct Mol Biol; 2009 Jun; 16(6):670-6. PubMed ID: 19448617
[TBL] [Abstract][Full Text] [Related]
11. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma.
Tremblay MP; Armero VE; Allaire A; Boudreault S; Martenon-Brodeur C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
BMC Genomics; 2016 Aug; 17(1):683. PubMed ID: 27565572
[TBL] [Abstract][Full Text] [Related]
12. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.
Liu J; Lee W; Jiang Z; Chen Z; Jhunjhunwala S; Haverty PM; Gnad F; Guan Y; Gilbert HN; Stinson J; Klijn C; Guillory J; Bhatt D; Vartanian S; Walter K; Chan J; Holcomb T; Dijkgraaf P; Johnson S; Koeman J; Minna JD; Gazdar AF; Stern HM; Hoeflich KP; Wu TD; Settleman J; de Sauvage FJ; Gentleman RC; Neve RM; Stokoe D; Modrusan Z; Seshagiri S; Shames DS; Zhang Z
Genome Res; 2012 Dec; 22(12):2315-27. PubMed ID: 23033341
[TBL] [Abstract][Full Text] [Related]
13. Mutational landscape of RNA-binding proteins in human cancers.
Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
[TBL] [Abstract][Full Text] [Related]
14. Aberrant posttranscriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression.
Adamia S; Kriangkum J; Belch AR; Pilarski LM
Adv Cancer Res; 2014; 123():67-94. PubMed ID: 25081526
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing: global insights.
Hallegger M; Llorian M; Smith CW
FEBS J; 2010 Feb; 277(4):856-66. PubMed ID: 20082635
[TBL] [Abstract][Full Text] [Related]
16. The Functional Impact of Alternative Splicing in Cancer.
Climente-González H; Porta-Pardo E; Godzik A; Eyras E
Cell Rep; 2017 Aug; 20(9):2215-2226. PubMed ID: 28854369
[TBL] [Abstract][Full Text] [Related]
17. A saga of cancer epigenetics: linking epigenetics to alternative splicing.
Narayanan SP; Singh S; Shukla S
Biochem J; 2017 Mar; 474(6):885-896. PubMed ID: 28270561
[TBL] [Abstract][Full Text] [Related]
18. rMAPS: RNA map analysis and plotting server for alternative exon regulation.
Park JW; Jung S; Rouchka EC; Tseng YT; Xing Y
Nucleic Acids Res; 2016 Jul; 44(W1):W333-8. PubMed ID: 27174931
[TBL] [Abstract][Full Text] [Related]
19. Opportunities and methods for studying alternative splicing in cancer with RNA-Seq.
Feng H; Qin Z; Zhang X
Cancer Lett; 2013 Nov; 340(2):179-91. PubMed ID: 23196057
[TBL] [Abstract][Full Text] [Related]
20. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
Urbanski LM; Leclair N; Anczuków O
Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
